{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:16Z","timestamp":1793356816650,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.euros.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:57:22Z","timestamp":1791935842000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Can We Omit Systematic Biopsies in Men with a Positive MRI During Repeat Biopsies for Active Surveillance for Prostate Cancer? Results from the PRIAS Study"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3457-2287","authenticated-orcid":false,"given":"Jeroen J.","family":"Lodder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Remmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lozano-Uru\u00f1uela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Papavassilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"Somford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Staerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl H.","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.09.006_b0005","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer","volume":"331","author":"Newcomb","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.09.006_b0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2021.12.007","article-title":"Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy","volume":"81","author":"Willemse","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.09.006_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.euros.2022.07.006","article-title":"An magnetic resonance imaging-directed targeted-plus-perilesional biopsy approach for prostate cancer diagnosis: \u201cless is more\u201d","volume":"43","author":"Hagens","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.006_b0025","first-page":"34","article-title":"Targeted biopsy is sufficient for men on active surveillance for early-stage prostate cancer","volume":"213","author":"Fakunle","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0035","unstructured":"German Society of Urolog. S3 guideline prostate cancer, v.8.1.2025. AWMF Web site. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/043-022OL."},{"key":"10.1016\/j.euros.2026.09.006_b0040","unstructured":"National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology, v.5.2026. Prostate cancer. National Comprehensive Cancer Network Web site. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1459."},{"key":"10.1016\/j.euros.2026.09.006_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejca.2016.07.012","article-title":"Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma","volume":"66","author":"Kweldam","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euros.2026.09.006_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","article-title":"Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups","volume":"77","author":"van Leenders","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bju.15065","article-title":"Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?","volume":"126","author":"Osses","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.09.006_b0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","article-title":"PRECISION study group. prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the Prostate from the Precision trial","volume":"3","author":"Giganti","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.09.006_b0075","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231130","article-title":"Global variation in magnetic resonance imaging quality of the prostate","volume":"309","author":"Giganti","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.euros.2026.09.006_b0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2214\/AJR.18.20796","article-title":"The evolution of MRI of the prostate: the past, the present, and the future","volume":"213","author":"Giganti","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.euros.2026.09.006_b0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bju.16579","article-title":"Clinical value of contralateral biopsies in men with unilateral MRI foci undergoing targeted biopsy","volume":"135","author":"Boesen","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.09.006_b0090","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.euo.2024.01.007","article-title":"The added value of side-specific systematic biopsy in patients diagnosed by magnetic resonance imaging-targeted prostate biopsy","volume":"7","author":"Bourgeno","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2026.09.006_b0095","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1007\/s00261-024-04753-3","article-title":"Performance of MR fusion biopsy, systematic biopsy and combined biopsy on prostate cancer detection rate in 1229 patients stratified by PI-RADSv2 score on 3T multi-parametric MRI","volume":"50","author":"Riskin-Jones","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.euros.2026.09.006_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euros.2025.01.006","article-title":"Omission of contralateral systematic biopsies in unilateral suspicious prostate cancer on magnetic resonance imaging: implications for radiation treatment selection","volume":"73","author":"van den Kroonenberg","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.006_b0105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/sim.6003","article-title":"Modeling grade progression in an active surveillance study","volume":"33","author":"Inoue","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.euros.2026.09.006_b0110","doi-asserted-by":"crossref","first-page":"150.e9","DOI":"10.1016\/j.urolonc.2016.11.010","article-title":"Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely?","volume":"35","author":"Fossati","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euros.2026.09.006_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bju.14659","article-title":"Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer","volume":"124","author":"Gupta","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.09.006_b0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncr.21643","article-title":"Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?","volume":"106","author":"Vickers","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2026.09.006_b0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12913-021-06916-0","article-title":"Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore","volume":"21","author":"Cheng","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.euros.2026.09.006_b0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JU.0000000000002497","article-title":"The effect of different types of prostate biopsy techniques on post-biopsy infectious complications","volume":"208","author":"Tops","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0135","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.eururo.2015.06.012","article-title":"Compliance rates with the prostate cancer research international active surveillance (PRIAS) protocol and disease reclassification in noncompliers","volume":"68","author":"Bokhorst","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.09.006_b0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bju.13410","article-title":"Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: active Surveillance (PRIAS) study","volume":"118","author":"Bokhorst","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.09.006_b0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.euros.2021.06.016","article-title":"Prostate cancer: is there still a role for systematic biopsies?","volume":"38","author":"Gandaglia","year":"2022","journal-title":"Yes. Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.006_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euros.2024.03.006","article-title":"The impact of omitting contralateral systematic biopsy on the surgical planning of patients with a unilateral suspicious lesion on magnetic resonance imaging undergoing robot-assisted radical prostatectomy for prostate cancer","volume":"63","author":"van den Kroonenberg","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2026.09.006_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prnil.2025.07.002","article-title":"Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions","volume":"14","author":"Roldan-Testillano","year":"2026","journal-title":"Prostate Int"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326033458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326033458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:03:54Z","timestamp":1793354634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326033458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S2666168326033458"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.006","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can We Omit Systematic Biopsies in Men with a Positive MRI During Repeat Biopsies for Active Surveillance for Prostate Cancer? Results from the PRIAS Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}